Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 62

Sort by

Sort Order Select

Journal Articles

Dynamics of Circulating Tumor DNA As a Predictor of Outcomes with Lisocabtagene Maraleucel in Relapsed or Refractory Large B-Cell Lymphoma from the Transcend NHL-001 Study

Dasom Lee, Brian J. Sworder, Lara Stepan, Abood Okal, Chang-Pin Huang, Xiaoman Kang, James Hamilton, Charles Macaulay, Mari Olsen, Chih Long Liu, Maximilian Diehn, Leanne Peiser, David Kurtz, Ash A. Alizadeh

Blood (2024) 144 (Supplement 1): 3410.

https://doi.org/10.1182/blood-2024-200924

Published: 2024

Journal Articles

Guiding Treatment and Clinical Management of Patients with CNS Lymphomas By Minimal-Invasive Detection of Circulating Tumor DNA in Cerebrospinal Fluid

Blood (2024) 144 (Supplement 1): 1583.

https://doi.org/10.1182/blood-2024-202943

Published: 2024

Journal Articles

Integrating Genomic & Transcriptomic Features for Noninvasive Detection, Characterization, and Monitoring of T-Cell Lymphomas

Blood (2024) 144 (Supplement 1): 454.

https://doi.org/10.1182/blood-2024-206518

Published: 2024

Journal Articles

Distinct Molecular Aberrations of Classic Hodgkin Lymphoma in Older Adults Identified By Comprehensive Genomic Profiling

Blood (2024) 144 (Supplement 1): 853.

https://doi.org/10.1182/blood-2024-201644

Published: 2024

Journal Articles

Acquired Immunodeficiency Landscapes Via Integrated Noninvasive Viral & Immune Profiling in HIV-Associated Lymphoproliferative Disease

Shuyu Shi, Kathryn Lurain, Joseph G. Schroers-Martin, Andrea Garofalo, Jurik A. Mutter, Takeshi Sugio, Xiaoman Kang, Feng Tian, Chih Long Liu, Mari Olsen, Wyndham H. Wilson, Maximilian Diehn, Mark Roschewski, Ash A. Alizadeh

Blood (2024) 144 (Supplement 1): 1157.

https://doi.org/10.1182/blood-2024-211308

Published: 2024

Journal Articles

Non-Invasive Characterization and Early Detection of Post-Transplant Lymphoproliferative Disorders

Blood (2024) 144 (Supplement 1): 648.

https://doi.org/10.1182/blood-2024-206532

Published: 2024

Journal Articles

Modulation of the Tumor Microenvironment By CCL19 in Primary CNS Lymphomas

Blood (2024) 144 (Supplement 1): 856.

https://doi.org/10.1182/blood-2024-199257

Published: 2024

Journal Articles

Direct Method for Estimating the Fraction of T and B/Plasma Cell-Derived DNA

Takeshi Sugio, Mohammad Shahrokh Esfahani, Soyeong Jun, Brian J. Sworder, Mark P. Hamilton, Hitomi Hosoya, Mari Olsen, Xiaoman Kang, Chih Long Liu, Feng Tian, David B. Miklos, David Kurtz, Maximilian Diehn, Ash A. Alizadeh

Blood (2024) 144 (Supplement 1): 2223.

https://doi.org/10.1182/blood-2024-193441

Published: 2024

Journal Articles

Resolving the Microarchitecture of Classic and Transformed Follicular Lymphoma By Single Cell Alignment to Spatial Transcriptomes

Troy Noordenbos, Joseph G. Schroers-Martin, Mark P. Hamilton, Soyeong Jun, Takeshi Sugio, Brian J. Sworder, Chloé Beate Steen, Mari Olsen, Chih Long Liu, Aaron Newman, Brooke Howitt, Yasodha Natkunam, David B. Miklos, Maximilian Diehn, Matthew J. Frank, Ash A. Alizadeh

Blood (2024) 144 (Supplement 1): 2993.

https://doi.org/10.1182/blood-2024-199300

Published: 2024

Journal Articles

Anatomic Genetic Heterogeneity Is Uncovered By Concurrent Cell-Free DNA and Tissue Profiling and Predicts Treatment Resistance in Diffuse Large B-Cell Lymphoma

Jordan S Goldstein, Florian Scherer, Brian J. Sworder, Maximilian Diehn, David Kurtz, Ash A. Alizadeh

Blood (2024) 144 (Supplement 1): 4357.

https://doi.org/10.1182/blood-2024-209735

Published: 2024

Journal Articles

The Effect of Ibrutinib on the Myeloid Cell Compartment in Central Nervous System Lymphoma Slice Cultures

Julia C. Kuehn, Nicolas N. Neidert, Junyi Zhang, Jurik A Mutter, Stefan K. Alig, Christian Klingler, Fabian Hummel, Sabine Bleul, Lavanya Ranganathan, Jürgen Beck, Marco Prinz, Maximilian Diehn, Ash A. Alizadeh, Justus Duyster, Roman Sankowski, Dieter Henrik Heiland, Florian Scherer

Blood (2024) 144 (Supplement 1): 4374.

https://doi.org/10.1182/blood-2024-199125

Published: 2024

Journal Articles

Ultrasensitive Circulating Tumor DNA MRD Status Predicts Treatment Failure & Complements PET/CT throughout Treatment for Early and Advanced Stage Classic Hodgkin Lymphoma

Jan Boegeholz, Cedric Rossi, Jordan S Goldstein, Stefan K. Alig, Andrea Garofalo, Mohammad Shahrokh Esfahani, Joseph G. Schroers-Martin, Chih Long Liu, Mari Olsen, Xiaoman Kang, Feng Tian, David Kurtz, Marc Andre, Luc-Matthieu Fornecker, Olivier Casasnovas, Maximilian Diehn, Herve Ghesquieres, Ash A. Alizadeh

Blood (2024) 144 (Supplement 1): 565.

https://doi.org/10.1182/blood-2024-201877

Published: 2024

Journal Articles

CAR19 Therapy Drives Expansion of Clonal Hematopoiesis and Associated Cytopenias

Blood (2023) 142 (Supplement 1): 360.

https://doi.org/10.1182/blood-2023-182522

Published: 2023

Journal Articles

Phased Variants Allow Robust Profiling of Circulating Tumor DNA in Untreated Follicular Lymphomas

Ákos Nagy, Bence Bátai, Gregory Hogan, Jacob J. Chabon, Mikayla Troke, Lance Riley, Andre Schultz, Sandra Close, Maximilian Diehn, Donát Alpár, Botond Timár, Ash A. Alizadeh, David M. Kurtz, Csaba Bödör

Blood (2023) 142 (Supplement 1): 1626.

https://doi.org/10.1182/blood-2023-189824

Published: 2023

Journal Articles

Inferred Gene Expression By Cell-Free DNA Profiling Allows Noninvasive Lymphoma Classification

Jurik A Mutter, Mohammad Shahrokh Esfahani, Joseph Schroers-Martin, Stefan K. Alig, Mark P. Hamilton, Brian J. Sworder, Benoit Tessoulin, Jan Boegeholz, Timothy Flerlage, Jamie E. Flerlage, Michael S. Binkley, Takeshi Sugio, Cédric Rossi, Mari Olsen, Chih Long Liu, Steven Le Gouill, David M. Kurtz, Maximilian Diehn, Ash A. Alizadeh

Blood (2023) 142 (Supplement 1): 245.

https://doi.org/10.1182/blood-2023-186853

Published: 2023

Journal Articles

Distinct Circulating Genomic Features of Classical Hodgkin Lymphoma of Older Adults

Cédric Rossi, Jan Boegeholz, Stefan K. Alig, Andrea Garofalo, Mohammad Shahrokh Esfahani, Joseph Schroers-Martin, Mari Olsen, Xiaoman Kang, David M. Kurtz, Takeshi Sugio, Mark P. Hamilton, Marc Andre, Rene-Olivier Casasnovas, Luc Matthieu Fornecker, Maximilian Diehn, Herve Ghesquieres, Ash A. Alizadeh

Blood (2023) 142 (Supplement 1): 4369.

https://doi.org/10.1182/blood-2023-178257

Published: 2023

Journal Articles

Optimizing Circulating Tumor DNA Limits of Detection for DLBCL during First Line Therapy

Jordan Goldstein, Won Seog Kim, Sang Eun Yoon, Seok Jin Kim, Mark Roschewski, Jason Westin, Ryan C Lynch, Stefan K. Alig, Sandra Close, Jacob J. Chabon, Davide Rossi, Wyndham H Wilson, Maximilian Diehn, Ash A. Alizadeh, David M. Kurtz

Blood (2023) 142 (Supplement 1): 187.

https://doi.org/10.1182/blood-2023-187759

Published: 2023

Journal Articles

Prognostic Utility of Minimal Residual Disease (MRD) after Curative Intent Induction Therapy for DLBCL: A Prospective Real-World Ctdna Study

Brian J. Sworder, Sang Eun Yoon, Seok Jin Kim, Andre Schultz, Gregory Hogan, Sandra Close, Jacob J. Chabon, Maximilian Diehn, David M. Kurtz, Ash A. Alizadeh, Won Seog Kim

Blood (2023) 142 (Supplement 1): 69.

https://doi.org/10.1182/blood-2023-187650

Published: 2023

Journal Articles

Longitudinal Noninvasive Surveillance & Fragmentomic Characterization of Follicular Lymphoma

Joseph Schroers-Martin, Jurik A Mutter, Mohammad Shahrokh Esfahani, Florian Scherer, Joanne Soo, Stefan K. Alig, David M. Kurtz, Takeshi Sugio, Cédric Rossi, Benoit Tessoulin, Mari Olsen, Chih Long Liu, Maximilian Diehn, Ash A. Alizadeh

Blood (2023) 142 (Supplement 1): 528.

https://doi.org/10.1182/blood-2023-187116

Published: 2023

Journal Articles

An Integrated Multimodal Framework for Noninvasive TCL Disease Detection and Monitoring

Takeshi Sugio, Navika Shukla, Michael S Khodadoust, Monica Nesselbush, Koji Kato, Stefan K. Alig, Jan Boegeholz, Joseph Schroers-Martin, Mohammad Shahrokh Esfahani, Jurik A. Mutter, Andrea Garofalo, Soyeong Jun, Mark P. Hamilton, Cédric Rossi, Mari Olsen, Chih Long Liu, Koichi Akashi, Maximilian Diehn, Ash A. Alizadeh

Blood (2023) 142 (Supplement 1): 1620.

https://doi.org/10.1182/blood-2023-180492

Published: 2023

NARROW

Dynamics of Circulating Tumor DNA As a Predictor of Outcomes with Lisocabtagene Maraleucel in Relapsed or Refractory Large B-Cell Lymphoma from the Transcend NHL-001 Study

Guiding Treatment and Clinical Management of Patients with CNS Lymphomas By Minimal-Invasive Detection of Circulating Tumor DNA in Cerebrospinal Fluid

Integrating Genomic & Transcriptomic Features for Noninvasive Detection, Characterization, and Monitoring of T-Cell Lymphomas

Distinct Molecular Aberrations of Classic Hodgkin Lymphoma in Older Adults Identified By Comprehensive Genomic Profiling

Acquired Immunodeficiency Landscapes Via Integrated Noninvasive Viral & Immune Profiling in HIV-Associated Lymphoproliferative Disease

Non-Invasive Characterization and Early Detection of Post-Transplant Lymphoproliferative Disorders

Modulation of the Tumor Microenvironment By CCL19 in Primary CNS Lymphomas

Direct Method for Estimating the Fraction of T and B/Plasma Cell-Derived DNA

Resolving the Microarchitecture of Classic and Transformed Follicular Lymphoma By Single Cell Alignment to Spatial Transcriptomes

Anatomic Genetic Heterogeneity Is Uncovered By Concurrent Cell-Free DNA and Tissue Profiling and Predicts Treatment Resistance in Diffuse Large B-Cell Lymphoma

The Effect of Ibrutinib on the Myeloid Cell Compartment in Central Nervous System Lymphoma Slice Cultures

Ultrasensitive Circulating Tumor DNA MRD Status Predicts Treatment Failure & Complements PET/CT throughout Treatment for Early and Advanced Stage Classic Hodgkin Lymphoma

CAR19 Therapy Drives Expansion of Clonal Hematopoiesis and Associated Cytopenias

Phased Variants Allow Robust Profiling of Circulating Tumor DNA in Untreated Follicular Lymphomas

Inferred Gene Expression By Cell-Free DNA Profiling Allows Noninvasive Lymphoma Classification

Distinct Circulating Genomic Features of Classical Hodgkin Lymphoma of Older Adults

Optimizing Circulating Tumor DNA Limits of Detection for DLBCL during First Line Therapy

Prognostic Utility of Minimal Residual Disease (MRD) after Curative Intent Induction Therapy for DLBCL: A Prospective Real-World Ctdna Study

Longitudinal Noninvasive Surveillance & Fragmentomic Characterization of Follicular Lymphoma

An Integrated Multimodal Framework for Noninvasive TCL Disease Detection and Monitoring

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only